secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001528287-25-000012
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace reports record Q1 revenue $22.5M (+24% YoY), raises FY2025 guidance to $93-97M
--------------------------------------------------------------------------------

- Record quarterly revenue $22.5M, up 24% YoY; RNS System revenue up 29% excluding NAUTILUS study implants.
- Gross margin 77.0% exceeded full-year guidance of 73-75%; operating loss narrowed to $5.1M from $7.5M.
- Full-year 2025 revenue guidance raised to $93-97M (16-21% growth); expects NAUTILUS topline data in H2 2025.
- Strategic refocus on core RNS System; terminating SEEG distribution relationship starting Q4 2025 through Q1 2026.
- Cash and investments $66.3M; long-term debt $59.8M as of March 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/0001528287-25-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828725000012/npce-20250513.htm
  HTML page:      https://secwatch.observer/filing/0001528287-25-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer